cancer%20pain
CANCER PAIN
Cancer pain is an unpleasant sensory & emotional experience due to actual or potential tissue damage in patients with cancer.
Effective pain management in cancer patients with pain is an essential part of oncologic management due to increasing evidence of survival.
Pancreatic, head & neck cancer has a high prevalence of cancer pain.
During initial evaluation, follow-ups and new therapy initiation of patients with cancer, it is essential that they will be screened & evaluated for pain.

Cancer%20pain Management

Follow Up

  • To ensure that the selected analgesic therapy has given the patient maximum benefit with as few adverse effects as possible, reassessment of pain intensity must be done at specified intervals
  • Patients on long-term opioid therapy should be assessed for abuse, addiction, tolerance or dependence
  • Consider opioid dose reduction by 10-20% in the following situations:
    • Breakthrough analgesic was rarely or never needed
    • Acute pain event has been completed
    • Improvement of pain control through use of non-opioid pain management therapies is evident
    • Well-controlled pain in the setting of stable disease
  • Opioid reduction by 10-25% can be considered in patients with unmanageable adverse effects and mild pain
    • Re-evaluate after dose reduction and have a close follow-up to make sure there is no pain escalation or withdrawal symptoms despite the dose reduction
  • Opioid reduction by 50-75% is necessary in patients who have significant safety issues

Specialist Referral

  • Patients may be referred to a psychiatrist for psychological support, or to a substance abuse specialist for patients on long-term opioid therapy with signs of drug addiction, abuse, dependence or tolerance
  • Consider physical or occupational therapy consultation for advice on the use of physical modalities
  • Orthopedic consultation should be considered in patients experiencing pain
  • Referral to a pain or palliative care specialist for refractory symptoms or intractable pain or for guidance on Methadone prescribing is recommended
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
4 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Yesterday
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.